SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-22-040723
Filing Date
2022-02-14
Accepted
2022-02-14 12:30:53
Documents
2
Group Members
ALPHABET HOLDINGS LLCALPHABET INC.GV 2016 GP, L.L.C.GV 2016 GP, L.P.GV 2017 GP, L.L.C.GV 2017 GP, L.P.GV 2017, L.P.GV 2019 GP, L.L.C.GV 2019 GP, L.P.GV 2019, L.P.XXVI HOLDINGS INC.

Document Format Files

Seq Description Document Type Size
1 SC 13G d262117dsc13g.htm SC 13G 242078
2 EX-99.A d262117dex99a.htm EX-99.A 15888
  Complete submission text file 0001193125-22-040723.txt   259812
Mailing Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215
Business Address 1325 BOYLSTON STREET SUITE 500 BOSTON MA 02215 617-370-8701
Decibel Therapeutics, Inc. (Subject) CIK: 0001656536 (see all company filings)

IRS No.: 464198709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92302 | Film No.: 22628116
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043
Business Address 1600 AMPHITHEATRE PARKWAY MOUNTAIN VIEW CA 94043 650-335-5278
GV 2016, L.P. (Filed by) CIK: 0001721789 (see all company filings)

IRS No.: 611775632 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G